---
title: "mPharma Joins Kenya Diabetes and Hypertension Care Program"
description: "mPharma is a partner in Boehringer Ingelheim’s Kenya Access to Healthcare program, tracking enrollment and adherence as it scales chronic care."
canonical_url: "https://liners.com/news/mpharma-kenya-access-to-healthcare-program"
markdown_url: "https://liners.com/news/mpharma-kenya-access-to-healthcare-program.md"
type: "article"
language: "en"
published_at: "2026-09-09T08:38:48.613Z"
updated_at: "2026-09-09T08:38:54.079Z"
---

# mPharma Joins Kenya Diabetes and Hypertension Care Program

mPharma is a partner in Boehringer Ingelheim’s Kenya Access to Healthcare program, tracking enrollment and adherence as it scales chronic care.

## Breadcrumbs

- [News](/news)
- [mPharma Joins Kenya Diabetes and Hypertension Care Program](/news/mpharma-kenya-access-to-healthcare-program)

## Content

## In Short
Boehringer Ingelheim’s Access to Healthcare program in Kenya is expanding support for people living with type 2 diabetes and hypertension. 

The program uses tiered drug pricing, nurse follow-ups, and community screening to reduce cost and travel barriers. 

Partners include digital health provider Zuri Health, MEDS, AMPATH, and mPharma.

## What Happened
[mPharma](/mpharma) is working as a partner in Boehringer Ingelheim’s Access to Healthcare program in Kenya. mPharma’s role is to track patient numbers, enrollment, and adherence.

“Adherence” means whether patients keep taking medication and following care plans over time. For chronic conditions like hypertension and type 2 diabetes, missed refills and skipped check-ups can lead to complications and avoidable hospital visits.

The program launched in 2022 and is designed as end-to-end care. That means it tries to cover the whole patient journey, not only the prescription.

The pathway includes community pop-up screening, physician diagnosis, eligibility checks, enrollment, and at least 12 months of follow-up. Follow-up is handled by nurses and health coaches who support patients with guidance and medication refills.

The partners split the operational work. [Zuri Health](/zuri-health) manages the patient journey using digital tools that work over SMS and USSD, which are mobile menus that run on basic phones without internet. MEDS supports medicine supply and distribution to facilities. AMPATH supports implementation across facilities.

A separate update on the program’s progress said it had reached over 140,000 patients. It also said more than 10,000 people were receiving treatment across 30+ facilities.

## Why It Matters
Kenya’s non-communicable disease burden is rising. The source data cited 1.8 million adults living with diabetes and about 5.5 million adults aged 30 to 79 with hypertension, with only 16% treated.

For African health systems, chronic care often fails at the “last mile”, cost, distance, and time away from work. A model that combines affordable medicines, local screening, and long follow-up cycles is closer to how these diseases need to be managed.

For health tech and pharmacy supply chain players, the program is also a signal. Large pharma companies are increasingly leaning on local digital and distribution partners to run measurable care programs, not only awareness campaigns.

## Sources and products

- [Morningstar, Inc.](https://www.morningstar.com/news/accesswire/1217574msn/from-barriers-to-bridges-expanding-access-to-healthcare-in-kenya)
- [mPharma](/mpharma)

## Related pages

- [Expansion & Partnerships](/news)

## Access and citation

- [Canonical HTML page](https://liners.com/news/mpharma-kenya-access-to-healthcare-program)
- [Markdown route index](/sitemap.md)
- [Agent access guide](/llms.txt)